Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares, rose in value, with the stock price up by 17.37% to the previous day’s close as strong demand from buyers drove the stock to $4.43.
Actively observing the price movement in the recent trading, the stock is buoying the session at $3.77. Referring to stock’s 52-week performance, its high was $4.10, and the low was $1.69. On the whole, XERS has fluctuated by 21.57% over the past month.
With the market capitalization of Xeris Biopharma Holdings Inc currently standing at about $659.69 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 239.77M, with a low estimate of 51.2M and a high estimate of 57M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 54.9M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that XERS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of XERS currently trading nearly 17.91% and 24.12% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 73.83, while the 7-day volatility ratio is showing 5.10% which for the 30-day chart, stands at 4.68%. Furthermore, Xeris Biopharma Holdings Inc (XERS)’s beta value is 1.34, and its average true range (ATR) is 0.22.
A comparison of Xeris Biopharma Holdings Inc (XERS) with its peers suggests the former has fared considerably weaker in the market. XERS showed an intraday change of 17.37% in today’s session so far, and over the past year, it grew by 45.56%%.
Data on historical trading for Xeris Biopharma Holdings Inc (NASDAQ:XERS) indicates that the trading volumes over the past 3 months, they’ve averaged 1.59 million. According to company’s latest data on outstanding shares, there are 149.00 million shares outstanding.
Nearly 7.55% of Xeris Biopharma Holdings Inc’s shares belong to company insiders and institutional investors own 44.79% of the company’s shares. The stock has risen by 30.53% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the XERS stock heading into the next quarter.
